INDIVIDUALIZED GENETIC MAKEUP THAT CONTROLS NATURAL KILLER CELL FUNCTION INFLUENCES THE EFFICACY OF ISATUXIMAB IMMUNOTHERAPY IN PATIENTS WITH MULTIPLE MYELOMA

被引：0
|
作者：
Rajalingam, R. [1 ]
Sun, H. [1 ]
Kong, D. [1 ]
Mace, S. [2 ]
Chiron, M. [2 ]
机构：
[1] Univ Calif San Francisco, Immunogenet & Transplantat Lab, San Francisco, CA 94143 USA
[2] Sanofi Res & Dev, Translat & Expt Med, Cambridge, MA USA
来源：
HUMAN IMMUNOLOGY | 2021年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P49
引用
收藏
页码：103 / 104
页数：2
相关论文
共 47 条
  • [1] Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma
    Sun, Haibo
    Martin, Thomas G.
    Marra, John
    Kong, Denice
    Keats, Jonathon
    Mace, Sandrine
    Chiron, Marielle
    Wolf, Jeffrey L.
    Venstrom, Jeffrey M.
    Rajalingam, Raja
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [2] Natural killer cell immunotherapy against multiple myeloma: Progress and possibilities
    Liu, Pan
    Jin, Yanxia
    Sattar, Haseeb
    Liu, Hailing
    Xie, Weiling
    Zhou, Fuling
    JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 103 (05) : 821 - 828
  • [3] Amelioration of natural killer cell function driven by invariant natural killer T cell activation in multiple myeloma
    Yamasaki, Satoru
    Iyoda, Tomonori
    Hidaka, Michihiro
    Kawano, Fumio
    Abe, Yu
    Suzuki, Kenshi
    Kadowaki, Norimitsu
    Shimizu, Kanako
    Fujii, Shin-ichiro
    CANCER SCIENCE, 2018, 109 : 109 - 109
  • [4] Targeting Mechanisms for Natural Killer Cell Dysfunction in Patients with Multiple Myeloma
    Jenkins, Misty
    Canfield, Rachael
    Robbins, Michael
    Ritchie, David S.
    Trapani, Joe
    Neeson, Paul
    BLOOD, 2015, 126 (23)
  • [5] Selinexor Enhances Natural Killer Cell Function Against Multiple Myeloma Cells
    Fisher, Jack G.
    Doyle, Amber D. P.
    Graham, Lara V.
    Forconi, Francesco
    Cragg, Mark S.
    Walker, Christopher J.
    Khakoo, Salim I.
    Blunt, Matthew D.
    BLOOD, 2023, 142
  • [6] Natural killer cell alloreactive haploidentical stem cell transplantation for multiple myeloma patients
    Elssen, Catharina
    Wieten, Lotte
    Von dem Borne, Peter
    Meijer, Ellen
    Bos, Gerard
    BONE MARROW TRANSPLANTATION, 2019, 54 : 605 - 605
  • [7] NATURAL-KILLER CELL-ACTIVITY IN PATIENTS WITH MULTIPLE-MYELOMA
    OGMUNDSDOTTIR, HM
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 133 - 143
  • [8] Natural-killer cell (NK)-infusion as adoptive immunotherapy in patients with multiple myeloma relapsing after allogeneic stem cell transplantation
    Wolschke, C.
    Sputtek, A.
    Stuebig, T.
    Worthmann, F.
    van Randenborgh, A.
    Ayuk, F.
    Zander, A. R.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S198 - S198
  • [9] The effect of elotuzumab on natural killer (NK) cell function against multiple myeloma (MM).
    Collins, S. M.
    Bakan, C. E.
    Alghothani, Y.
    Kwon, H.
    Balasa, B.
    Starling, G.
    Rice, A.
    Benson, D. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Myeloma Can Modulate Expanded Natural Killer Cell Function Through Multiple Mechanisms
    Garg, Tarun K.
    Khan, Junaid
    Stivers, Justin
    Szmania, Susann
    Greenway, Amy D.
    Lingo, Joshuah D.
    Stone, Katie
    Woods, Emily
    Barlogie, Bart
    Epstein, Joshua
    van Rhee, Frits
    BLOOD, 2012, 120 (21)
12345